COA Available
Performance In Stock Research Use Only
Tesamorelin
5mg · Lyophilized Powder · Purity ≥99%
Tesamorelin is a synthetic 44-amino-acid analogue of growth hormone-releasing hormone (GHRH) incorporating a trans-3-hexenoic acid modification that enhances peptide stability relative to native GHRH. It is studied in research examining GHRH receptor signalling, cAMP/PKA-mediated GH gene transcription, and pulsatile growth hormone release dynamics in pituitary somatotroph models.
$99.99 CAD
Purchase Options
Subscriptions can be managed from your customer account. Prices in CAD.
Research Overview
Tesamorelin binds selectively to GHRH receptors on pituitary somatotroph cells and initiates a cAMP/PKA signalling cascade leading to GH gene transcription and release. Its stabilising modification differentiates it from native GHRH(1-44) in half-life studies and makes it a useful reference compound for comparative receptor binding and downstream signalling research. BME Health supplies Tesamorelin at ≥98% purity by HPLC, with full COA documentation available per batch. Supplied exclusively for laboratory and research use.
Preclinical and mechanistic studies have used Tesamorelin to characterise GHRH receptor pharmacology, including receptor occupancy, cAMP accumulation kinetics, and PKA-mediated transcriptional activation in pituitary cell lines. It has also been applied in research models investigating downstream IGF-1 modulation secondary to GH release. The stabilised GHRH analogue framework makes it a frequently employed positive control in GHRH receptor binding assay development. All outcomes referenced pertain to preclinical models and do not constitute evidence of clinical efficacy or safety in humans.
Specifications
| Compound | Tesamorelin |
| Format | Lyophilized Powder |
| Size | 5mg |
| Purity (HPLC) | ≥99% |
| Item # | BME-TESAMO-A |
| Storage | −20°C, dry, dark |
| Price (CAD) | $99.99 |
COA / Testing
Batch documentation and third-party testing information are available for batch BME-TESAMO-A. COA previews appear only when documentation exists for the active batch.
Storage & Handling
Store lyophilised Tesamorelin at −20°C in its original sealed vial, protected from moisture and direct light. Avoid repeated freeze-thaw cycles, which reduce peptide stability and may affect assay results. Once reconstituted, the solution should be aliquoted immediately and stored at −80°C; refer to the COA for lot-specific stability parameters.
Shipping & Returns
Orders are processed on business days. Packaging is selected to maintain compound integrity in transit. Shipping timelines and return conditions are outlined in full in the Shipping & Returns policy — review before checkout if you have specific requirements. For orders with time-sensitive research schedules, contact support before placing your order.
Research Use Disclaimer
This product is supplied strictly for in-vitro and laboratory research use. It is not a drug, food supplement, or cosmetic and is not approved for human or veterinary clinical applications, diagnostics, or therapeutic use. Researchers are responsible for compliance with all applicable institutional and regulatory requirements in their jurisdiction.
Preparation Reference Guide
Research Solution Reference Calculator
Pre-filled with 5mg. Enter your solvent volume and target amount to see concentration and units on a U-100 syringe scale.
Concentration—
Volume to draw—
Syringe units (U-100)—
Per insulin unit—
For research-use calculations only. Always verify measurements independently — not medical guidance.
Questions before you order?
Browse the FAQ for documentation, storage, and sourcing answers, or contact our support team directly. We aim to respond to all research procurement inquiries within one business day.
Related
